+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Botulinum Toxin - Global Market Trajectory & Analytics

  • PDF Icon

    Report

  • 353 Pages
  • July 2022
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 516890

Global Botulinum Toxin Market to Reach $7.9 Billion by 2026


Botulinum toxin, a neurotoxin produced by Clostridium Botulinum bacterium, is capable of arresting release of acetylcholine, thus leading to muscle relaxation. Manufactured under controlled laboratory conditions and administered in extremely small therapeutic doses, BTX is administered intravenously only at the affected site. Growth in the global market is driven by growing demand in medical/therapeutic and cosmetic applications. While advancements in research and development of botulinum toxin have revolutionized medical and therapeutic uses over the past few decades, the largest opportunity has emerged from the facial aesthetics space. The growing acceptance of facial injectables such as BTX to facial aesthetics among adults and approval for using therapeutic BTX in the treatment of an expanded range of indications is expected to spur market expansion. The constant development and launch of novel products for enhancing aesthetic appeal and the growing demand for minimally invasive treatments in cosmetology as well as therapeutic applications are boosting demand in the market. In the field of neuromuscular therapeutics, the use of botulinum toxin is driven by rising incidences of movement related disorders and growing number of patients with muscle spasms. Further, new clinical indications of botulinum toxin such as in the treatment of nystagmus, stridor, palatal myoclonus, scoliosis, co-spasms following brachial plexus lesions (birth related), and gait freezing (Parkinson), have helped further strengthen growth in this space.

Amid the COVID-19 crisis, the global market for Botulinum Toxin estimated at US$5.6 Billion in the year 2022, is projected to reach a revised size of US$7.9 Billion by 2026, growing at a CAGR of 8.2% over the analysis period. Type A, one of the segments analyzed in the report, is projected to record 8.2% CAGR and reach US$8.5 Billion by the end of the analysis period. After a thorough analysis of the business implications of the pandemic and its induced economic crisis, growth in the Type B segment is readjusted to a revised 6.9% CAGR for the next 7-year period. Botulinum toxin type A finds use in the treatment of movement disorders, vocal cord dysfunction and obesity, and is also used as a medical aid in gastric cancer. Growth in the botulinum toxin type A will be driven by its increasing use in the treatment of muscle spasms in cerebral palsy as well as neurogenic bladder diseases occurring in children. Type B is used for various muscle related conditions. Botulinum neurotoxin type B was approved by the FDA in 2000 for treatment of for the treatment of adults with cervical dystonia to reduce the severity of abnormal head position and neck pain linked with cervical dystonia.

The U.S. Market is Estimated at $3.3 Billion in 2022, While China is Forecast to Reach $665 Million by 2026


The Botulinum Toxin market in the U.S. is estimated at US$3.3 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$665 Million by the year 2026 trailing a CAGR of 14.8% over the analysis period. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 8.1% and 6.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 9.1% CAGR. The United States represents the largest regional market, driven mainly by the growing approval for newer therapeutic indications. Further the increasing focus on improving physical appearance, rising disposable incomes of people, and the subsequent rise in demand for cosmetic procedures is also fueling growth. Rising demand for non-invasive or minimally invasive aesthetic treatments is also contributing to the growth of Botox market in the US. Europe also offers attractive opportunities for the botox market owing to the presence of a large number of cosmetic product manufacturers. Rapidly improving socio-economic conditions and proliferation of medical tourism, particularly in Asian countries, presents favorable prospects for botulinum toxin in Asia-Pacific region.

Select Competitors (Total 28 Featured):

  • AbbVie
  • Daewoong Pharmaceutical Co., Ltd.
  • HUGEL Pharma
  • Ipsen Group
  • Medy-Tox Inc.
  • Merz Pharma GmbH & Co. KGaA
  • Metabiologics, Inc.
  • Revance Therapeutics, Inc.
  • US WorldMeds

What`s New for 2022?

  • Global competitiveness and key competitor percentage market shares
  • Market presence across multiple geographies - Strong/Active/Niche/Trivial
  • Online interactive peer-to-peer collaborative bespoke updates
  • Access to the digital archives
  • Complimentary updates for one year
Frequently Asked Questions about the Global Market for Botulinum Toxin

What is the estimated value of the Global Market for Botulinum Toxin?

The Global Market for Botulinum Toxin was estimated to be valued at $5.6 Billion in 2022.

What is the growth rate of the Global Market for Botulinum Toxin?

The growth rate of the Global Market for Botulinum Toxin is 9.0%, with an estimated value of $7.9 Billion by 2026.

What is the forecasted size of the Global Market for Botulinum Toxin?

The Global Market for Botulinum Toxin is estimated to be worth $7.9 Billion by 2026.

Who are the key companies in the Global Market for Botulinum Toxin?

Key companies in the Global Market for Botulinum Toxin include AbbVie, Daewoong Pharmaceutical Co., Ltd., HUGEL Pharma, Ipsen Group, Medy, Tox Inc., Merz Pharma GmbH & Co. KGaA, Metabiologics, Inc. and US WorldMeds.

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Impact of Covid-19 and a Looming Global Recession
  • COVID-19 Disruptions Impact Botulinum Toxin Business
  • Virtual Care to the Fore amid COVID-19
  • Aesthetic Clinics to Follow Infection-Prevention Measures to Mitigate Risk of COVID-19 Infection Transmission
  • % Rise in Migraine Attacks due to COVID-19 Pandemic for March 2020
  • COVID-19 Disruptions Highlight Significance of Botulinum Toxin Therapy for Associated Medical Conditions
  • Researchers Eye on Botulinum Toxin as Potential Therapeutic Option to Alleviate and Manage COVID-19 Infection
  • Botulinum Toxin - Global Key Competitors Percentage Market Share in 2022 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
  • Botulinum Toxin: An Introduction
  • Outlook
  • Therapeutic BTX Applications Lead
  • Cosmetic BTX Gradually Gains Momentum
  • Factors Propelling the Cosmetic BT Market: In a Nut Shell
  • Percent of Plastic Surgeons Performing Botulinum Toxin Surgical Procedures in Select Countries: 2019
  • Developed Regions Dominate Botulinum Toxin Market
  • Developing Markets to Drive Future Growth
  • Competitive Landscape
  • Intense Competition Characterizes Botulinum Toxin Market
  • Market Share of Leading Players in Global Botulinum Toxin Market: 2019
  • Select Approved Botulinum Toxin Products Worldwide
  • Companies Entering the Fray
  • Pharma Companies Eye Lucrative BT Market
  • Biosimilar BTX Variants Challenge Botox’s Leadership
  • Lack of Differentiation among Approved BTX Products
  • Comparison of Leading Neurotoxins - Botox, Dysport and Xeomin by Safety and Efficacy
  • Comparison of Botox®, Dysport® and Xeomin® by Indications and Year of Approval
  • BOTOX®
  • Approvals and Indications of Botox in Select Regions
  • Botox Therapeutic Approvals in the US by Indication
  • Ipsen Counts on New Indications for Future Growth of Dysport
  • Xeomin®
  • Merz
  • Other Products
  • Recent Market Activity
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Rising Demand for Non-Invasive Cosmetic Treatments Bodes Well for BTX Market
  • Non-Surgical Cosmetic Procedures Worldwide (2018): Percentage Breakdown of Procedure Volumes
  • Botulinum Toxin: The Preferred Solution in Facial Injectables Market
  • Cosmetic Botulinum Toxin Procedures Performed Worldwide (2019): Percentage Breakdown of Procedure Volume by Gender
  • Millennials: A Popular Demographic for Botulinum Toxin
  • Cosmetic Botulinum Toxin Procedures Performed Worldwide (2019): Percentage Breakdown of Procedure Volume by Age Group Age Group % Share
  • Therapeutic Areas and Opportunities
  • Botox Therapeutic Applications Uses and Indications
  • Global Therapeutic BTX Neurotoxin Market Breakdown by Therapeutic Indication (2019)
  • Botulinum Toxin Remains Gold Standard for Treatment of Focal Spasticity
  • Rise in the Number of Musculoskeletal Indications: Potential for Growth
  • Unmet Medical Needs Encourage Off-Label Use: A Cause for Concern or Jubilation?
  • Combination Therapies: A Double Whammy Success
  • Botulinum Toxin: Potential Applications in Treatment of Dental Diseases
  • Potential Applications in Dentistry
  • Short-lived Aesthetic Effects: A Strong Business Case for Revision Treatments
  • Novel Injection Systems for Highly Precise Dosage of Botulinum Toxin
  • Longer Life Expectancy and Rising Disposable Incomes Propel Sales of Cosmetic BTX
  • Life Expectancy at Birth in Years of People in Select Countries
  • Life Expectancy at Birth (in Years) of Men and Women by Region
  • Increase in Healthcare Spending Stirs Demand for BTX in Therapeutic Applications
  • Current Health Expenditure (CHE) as Percentage Of Gross Domestic Product (GDP) (%): 2017
  • World Healthcare Expenditure (In US$ Billion) for the Years 2017-2023
  • Challenges and Issues
  • Undesirable Side Effects: A Challenge to Reckon With
  • Immunogenicity Undermines Patient Compliance
  • Antigenicity: A Problematic Issue in Drug Development
  • Potential Adverse Side Effects: A Major Barrier to Success
  • Stringent Regulations Delay Market Approvals
  • Higher Product Costs to Challenge Market Growth
  • Consumer Skepticism: The Biggest Challenge to Beat
  • Animal Cruelty:A Part & Parcel of Botox Testing
4. GLOBAL MARKET PERSPECTIVEIII. MARKET ANALYSIS
UNITED STATES
  • Botulinum Toxin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2022 (E)
  • Market Overview
  • Opportunities in Store for Cosmetic BTX
  • Age-wise Distribution for Botulinum Toxin Procedures Performed in the US for the Year 2019
  • Gender Distribution for Botulinum Toxin Procedures Performed in the US (2019)
  • Increasing Demand for Cosmetic Treatments Bodes Well for BTX Market
  • Cosmetic Procedures: Facts and Figures
  • Number of Surgical & Non-Surgical Cosmetic Procedures ('000s) in the US for the Years 2000, 2018 & 2019
  • Top 5 Surgical Cosmetic Procedures in the US - Ranked by the Number of Procedures Performed (In ‘000s) for 2019
  • Top 4 Non-Surgical Cosmetic Procedures in the US - Ranked by the Number of Procedures Performed (‘000s) for 2019
  • Number of Botulinum Toxin Procedures* Performed in the US: 2000, 2016 and 2019
  • Aging Baby Boomers Drive Aesthetic Business
  • US Population by Age Group (2017): Percentage Breakdown for 0-14, 15-24, 25-59 and 65+ Age Groups
  • North American Aging Population by Age Group: 1975-2050
  • Expanding Physician Base Extends Impetus to Growth
  • Therapeutic BTX Seeks Growth Opportunities
  • Approved Therapeutic Indications of Botulinum Toxin in the US by Year of Approval
  • Neurogenic OAB: A Lucrative Market Opportunity
  • Competitive Landscape
  • Major BTX Products and Associated Fillers in the Cosmetic Botulinum Toxin Market
  • Market Share of Leading Brands in the US Boulinum Toxin Market: 2019
  • Dysport Poses Strong Competition to Botox in the Therapeutic Space
CANADA
JAPAN
  • Botulinum Toxin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2022 (E)
  • Market Overview
  • Non-Surgical Aesthetic Procedures in Japan (2019): Percentage Breakdown of Number of Procedures by Procedure Type Procedure % Share
CHINA
  • Botulinum Toxin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2022 (E)
  • Market Overview
  • Uptrend in Facial Injectables Market Favors Market Expansion
  • Regulatory Scenario
  • Approved Botulinum Toxin Injections in China
  • Competition
  • Market Share of Leading Players in Chinese Botulinum Toxin Market: 2019
EUROPE
  • Botulinum Toxin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2022 (E)
  • Market Overview
  • Botox Approvals and Indications in Select European Countries
  • Non-Surgical Aesthetic Procedures in Select European Countries (2019): Percentage Breakdown of Number of Procedures by Procedure Type
  • Regulations for Botulinum Toxin Usage in the EU
FRANCE
  • Botulinum Toxin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2022 (E)
GERMANY
  • Botulinum Toxin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2022 (E)
ITALY
UNITED KINGDOM
  • Botulinum Toxin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2022 (E)
  • Market Overview
  • Snapshots
SPAIN
RUSSIA
  • Market Overview
REST OF EUROPE
ASIA-PACIFIC
  • Botulinum Toxin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2022 (E)
AUSTRALIA
  • Botulinum Toxin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2022 (E)
  • Market Overview
  • Non-Surgical Aesthetic Procedures in Australia (2019): Percentage Breakdown of Number of Procedures by Procedure Type
INDIA
  • Botulinum Toxin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2022 (E)
  • Market Overview
  • Non-Surgical Aesthetic Procedures in India (2019): Percentage Breakdown of Number of Procedures by Procedure Type
SOUTH KOREA
  • Market Overview
  • Strong Demand for Cosmetic Procedures - Potential for BTX Market
  • Working Women as % of Total Female Population for 2005, 2010, 2015 & 2018
  • Foreign Patients Visiting Korea for Plastic Surgery & Dermatology Procedures as a % of Total Visits of Foreign Patients
  • Competition
  • Market Share of Leading Players in Botulinum Toxin Market In South Korea
REST OF ASIA-PACIFIC
LATIN AMERICA
  • Botulinum Toxin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2022 (E)
REST OF WORLD
IV. COMPETITION
  • Total Companies Profiled: 28

Companies Mentioned

A selection of companies mentioned in this report includes:

  • AbbVie
  • Daewoong Pharmaceutical Co., Ltd.
  • HUGEL Pharma
  • Ipsen Group
  • Medy-Tox Inc.
  • Merz Pharma GmbH & Co. KGaA
  • Metabiologics, Inc.
  • Revance Therapeutics, Inc.
  • US WorldMeds